Clinical Research Directory
Browse clinical research sites, groups, and studies.
Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections
Sponsor: Stephanie Wang Zuo
Summary
Due to rising antibiotic resistance, there has been a focus on non-antibiotic prophylactic measures for postmenopausal patients with recurrent urinary tract infections (rUTI), one of which is the safe and efficacious option of vaginal estrogen therapy. Standard application of vaginal estrogen cream entails intravaginal application of the cream twice a week, but some providers counsel patients with rUTI to apply a small, pea-sized amount to the periurethral area. This ideally reduces the amount of vaginal estrogen used while attaining a similar effect. However, to date, there is no data to prove that the periurethral technique of application is similar or non-inferior to intravaginal application in preventing UTI.
Official title: Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections: TAPER (Techniques of APplying Vaginal Estrogen for Prevention of Recurrent Urinary Tract Infections) Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
114
Start Date
2023-01-03
Completion Date
2025-06-25
Last Updated
2026-09-24
Healthy Volunteers
No
Conditions
Interventions
Periurethral application of estradiol cream
The experimental group will apply estradiol cream in a different location (periurethral) and at a smaller dose (0.5 gram) compared to the control group.
Intravaginal application of estradiol cream
The control group will apply 1 gram estradiol cream intravaginally using an applicator.
Locations (4)
UPMC Lemieux Sports Complex
Cranberry Township, Pennsylvania, United States
UPMC Hamot
Erie, Pennsylvania, United States
University of Pittsburgh Medical Center-Magee Womens Hospital
Pittsburgh, Pennsylvania, United States
UPMC Passavant-McCandless
Pittsburgh, Pennsylvania, United States